These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34986589)

  • 21. [Diagnosis of cannabinoid hyperemesis : update on the cannabis-shower syndrome].
    Cuppens B; Gensburger M; Tonglet M; Marissiaux L; Brasseur E; d'Orio V; Ghuysen A
    Rev Med Liege; 2016 Dec; 71(12):541-545. PubMed ID: 28387093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabinoid hyperemesis syndrome: clinical diagnosis of an underrecognised manifestation of chronic cannabis abuse.
    Sontineni SP; Chaudhary S; Sontineni V; Lanspa SJ
    World J Gastroenterol; 2009 Mar; 15(10):1264-6. PubMed ID: 19291829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabinoid hyperemesis syndrome.
    Heise L
    Adv Emerg Nurs J; 2015; 37(2):95-101. PubMed ID: 25929220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cannabinoid hyperemesis syndrome causing prolonged nausea and vomiting in patients with cannabis abuse].
    Naver AV; Theede K
    Ugeskr Laeger; 2015 Apr; 177(18):. PubMed ID: 25922240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A patient with a curious case of cyclical vomiting.
    Phillips HR; Smith DA
    JAAPA; 2017 Feb; 30(2):1-3. PubMed ID: 28098679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cannabinoid hyperemesis syndrome: about 6 cases].
    Bertolino J; Abdo L; Khau D; Meckenstock R; Sautereau N; Jean E; Greder-Belan A; Frances Y; Cabane J; Granel B
    Rev Med Interne; 2015 Oct; 36(10):694-7. PubMed ID: 25547957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabinoid hyperemesis syndrome: Review of the literature and of cases reported to the French addictovigilance network.
    Schreck B; Wagneur N; Caillet P; Gérardin M; Cholet J; Spadari M; Authier N; Tournebize J; Gaillard M; Serre A; Carton L; Pain S; Jolliet P; Victorri-Vigneau C
    Drug Alcohol Depend; 2018 Jan; 182():27-32. PubMed ID: 29132050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cannabis hyperemesis syndrome].
    Bonnet U; Chang DI; Scherbaum N
    Fortschr Neurol Psychiatr; 2012 Feb; 80(2):98-101. PubMed ID: 21692016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reply to Letter "Cannabis-Related Cyclic/Episodic Hyperemesis Conditions: From Suspected to Definitive Cannabinoid Hyperemesis Syndrome".
    Senderovich H; Patel P; Jimenez Lopez B; Waicus S
    Med Princ Pract; 2022; 31(5):499-500. PubMed ID: 35817006
    [No Abstract]   [Full Text] [Related]  

  • 30. Rates of Prenatal Cannabis Use Among Pregnant Women Before and During the COVID-19 Pandemic.
    Young-Wolff KC; Ray GT; Alexeeff SE; Adams SR; Does MB; Ansley D; Avalos LA
    JAMA; 2021 Nov; 326(17):1745-1747. PubMed ID: 34570168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cannabinoid hyperemesis with the unusual symptom of compulsive bathing].
    Boeckxstaens GE
    Ned Tijdschr Geneeskd; 2005 Jun; 149(26):1468-71. PubMed ID: 16010960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabinoid hyperemesis syndrome.
    Valdivielso Cortázar E; Ucha Abal P; Alonso Aguirre P
    Rev Esp Enferm Dig; 2018 May; 110(5):334-335. PubMed ID: 29745720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cannabinoid hyperemesis syndrome].
    Stuijvenberg MP; Ramaekers GM; Bijpost Y
    Ned Tijdschr Geneeskd; 2011; 155():A2880. PubMed ID: 21426598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marijuana induced hyperemesis: a case report.
    Gessford AK; John M; Nicholson B; Trout R
    W V Med J; 2012; 108(6):20-2. PubMed ID: 23472537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cannabis hyperemesis syndrome characterized by persistent nausea and vomiting, abdominal pain, and compulsive bathing associated with chronic marijuana use: a report of eight cases in the United States.
    Soriano-Co M; Batke M; Cappell MS
    Dig Dis Sci; 2010 Nov; 55(11):3113-9. PubMed ID: 20130993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-Potency Cannabis Use in Adolescence.
    Vargas G; Shrier LA; Chadi N; Harris SK
    J Pediatr; 2023 Jan; 252():191-197.e1. PubMed ID: 35977620
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cannabis must not be considered as a mild drug].
    Nau JY
    Rev Med Suisse; 2014 Apr; 10(424):770-1. PubMed ID: 24772812
    [No Abstract]   [Full Text] [Related]  

  • 38. Cannabis-related psychotic disorder upon relapse to cannabis use: A case series and possible neurobiological implications.
    Bharadwaj B; Navin K; Kuppili PP
    Asian J Psychiatr; 2018 Mar; 33():42-44. PubMed ID: 29524790
    [No Abstract]   [Full Text] [Related]  

  • 39. [Related, induced and associated psychiatric disorders to cannabis].
    Laqueille X
    Rev Prat; 2005 Jan; 55(1):30-4. PubMed ID: 15801394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The utility of droperidol in the treatment of cannabinoid hyperemesis syndrome.
    Lee C; Greene SL; Wong A
    Clin Toxicol (Phila); 2019 Sep; 57(9):773-777. PubMed ID: 30729854
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.